Viewing Study NCT06554535

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2026-07-22 @ 10:54 PM
Study NCT ID: NCT06554535
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-15
First Post: 2024-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extensive-Stage Small Cell Lung Cancer View
None Treatment-naïve for Systemic Therapy Targeting Extensive-Stage Small Cell Lung Cancer View
None ECOG Performance Status Score of 0 or 1 View
None Expected Survival ≥3 Months View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ES-SCLC View
None Chemo-immunotherapy combination View
None Aspirin View